Top Clinical Trials companies in Belgium by Net Cash Used For Investing Activities
This ranking features the top 4 Clinical Trials companies in Belgium ranked by Net Cash Used For Investing Activities, totaling a Net Cash Used For Investing Activities of USD 109.18 M, for February 08, 2025.
Belgium
Clinical Trials
Net Cash Used For Investing Activities
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 78.57 M
|
Dec. 31, 2023 | USD 23.14 | 1.75% |
|
Belgium |
|
| 2 |
USD 35.33 M
|
Dec. 31, 2023 | USD 10.80 | 2.86% |
|
Belgium |
|
| 3 |
USD -796.21 K
|
Dec. 31, 2023 | USD 2.20 | -1.56% |
|
Belgium |
|
| 4 |
USD -3.93 M
|
Dec. 31, 2023 | USD 1.91 | 0.00% |
|
Belgium |
Frequently Asked Questions
-
Which Clinical Trials company in Belgium has the highest Net Cash Used For Investing Activities ?
The Clinical Trials company in Belgium with the highest Net Cash Used For Investing Activities is Galapagos NV (Amsterdam Stock Exchange: GLPG.AS) at USD 78.57 M.
-
Which Clinical Trials company in Belgium has the lowest Net Cash Used For Investing Activities ?
The Clinical Trials company in Belgium with the lowest Net Cash Used For Investing Activities is MDxHealth SA (NasdaqCM: MDXH) at USD -3.93 M.
-
What are the top 10 Clinical Trials companies in Belgium by Net Cash Used For Investing Activities ?
The top 10 Clinical Trials companies in Belgium by Net Cash Used For Investing Activities are Galapagos NV, Nyxoah S.A., Sequana Medical NV and MDxHealth SA.
-
What are the bottom 10 Clinical Trials companies in Belgium by Net Cash Used For Investing Activities ?
The bottom 10 Clinical Trials companies in Belgium by Net Cash Used For Investing Activities are MDxHealth SA, Sequana Medical NV, Nyxoah S.A. and Galapagos NV.
